[New paradigm of herpes simplex virus type 1 thymidine kinase (HSV-TK)/ganciclovir (GCV)].
Nawa
Akihiro
A
Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine.
Ishida
Daisuke
D
ChenHong
Luo
L
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D015774:Ganciclovir / Q000627:therapeutic use*; D015316:Genetic Therapy / Q000379:methods; D018259:Herpesvirus 1, Human / Q000201:enzymology*; D006801:Humans; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D011355:Prodrugs / Q000627:therapeutic use*; D013937:Thymidine Kinase / Q000235:genetics* / Q000627:therapeutic use*
D000998:Antiviral Agents; D011355:Prodrugs; D013937:Thymidine Kinase; D015774:Ganciclovir